Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to AJANI, JAFFER A
Item TypeName
Concept Forecasting
Academic Article Radiation Therapy Oncology Group. Research Plan 2002-2006. Medical Oncology Committee.
Academic Article Radiation Therapy Oncology Group. Research Plan 2002-2006. Gastrointestinal Cancer Committee.
Academic Article Carcinoid--a comprehensive review.
Academic Article Upper gastrointestinal tumors: current status and future perspectives.
Academic Article Localized squamous cell carcinoma of the esophagus: bimodality or trimodality approach?
Academic Article Future developments in esophageal cancer research.
Academic Article A comprehensive review of S-1 in the treatment of advanced gastric adenocarcinoma.
Academic Article Ramucirumab: a novel antiangiogenic agent.
Academic Article Molecular epidemiology of gastric cancer: current status and future prospects.
Academic Article Section IV: Significance of Recent Study Results and Future Research Directions in Gastrointestinal Oncology.
Academic Article Current concepts and future potential in neoadjuvant chemotherapy for esophageal cancer
Academic Article Current concepts and future potential in neoadjuvant chemotherapy for esophageal cancer.
Academic Article Translating genomic profiling to gastrointestinal cancer treatment.
Academic Article Current status of ramucirumab in gastroesophageal adenocarcinoma.
Academic Article Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives.
Academic Article Programmed death ligand-1 expression in gastrointestinal cancer: Clinical significance and future challenges.
Academic Article Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives.
Academic Article PD-L1 expression and overall survival in Asian and western patients with gastric cancer.
Academic Article HERIZON-GEA-01: Zanidatamab + chemo?? tislelizumab for 1L treatment of HER2-positive gastroesophageal adenocarcinoma.
Academic Article Nivolumab with or without chemotherapy for metastatic gastroesophageal cancers and future perspectives.
Search Criteria
  • Forecasting